6505-01-239-2460 ( NDC50445-0111-01 , VELOSULIN HUMAN )
NSN Information
| NSN | FSC | NIIN | Item Name | INC |
|---|---|---|---|---|
| 6505-01-239-2460 | 6505 | 012392460 | INSULIN HUMAN INJECTION,USP | 3881 |
NSN Features
| MRC | Parameter | Characteristics |
|---|---|---|
| AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 100.000 UNITS INSULIN PER MILLILITER |
| CRMW | RAW MATERIAL SOURCE | PORCINE INTESTINAL MUCOSA |
| THPE | THERAPEUTIC EQUIVALENT | NOT LISTED |
| CQCT | PRIMARY CONTAINER TYPE | VIAL |
| FEAT | SPECIAL FEATURES | DERIVED FROM PORCINE SOURCE WITH ENZYME ALTERATIONS TO ACHIEVE INSULIN IDENTICAL TO HUMAN INSULIN |
| CRLK | PRIMARY CONTAINER CONTENT QUANTITY | 10.000 MILLILITERS |
| CSGS | ADMINISTRATION | SUBCUTANEOUS |
Manufacturing Part Numbers (SKUs)
| Part SKU | Cage | Status | RNVC | RNCC | SADC | DAC | RNAAC |
|---|---|---|---|---|---|---|---|
| NDC50445-0111-01 | 60554 | A | 2 | 3 | 6 | 54 | |
| VELOSULIN HUMAN | 60554 | A | 1 | 5 | 6 | 54 |
Manufacturers
| Part SKU | Cage | Manufacturer | Type | Status |
|---|---|---|---|---|
| NDC50445-0111-01 | 60554 | NOVO NORDISK INC. | A | A |
| VELOSULIN HUMAN | 60554 | NOVO NORDISK INC. | A | A |
FLIS Identification
| PMIC | ADPE Code | CRITL Code | DEMIL Code | DEMIL INTG | NIIN Asgt | ESD | HMIC | ENAC | Schedule-B | INC |
|---|---|---|---|---|---|---|---|---|---|---|
| A | X | A | 1 | 08/27/1 | P | 3004310000 | 3881 |
FLIS Management
| MOE | REC Rep Code | Mgmt Ctl | USC | Phrase Code | Phrase Statement |
|---|---|---|---|---|---|
| VA | V | K | U/I CONTAINS 10 ML |
Demilitarization Codes & Management
| DML | PMI | HMIC | ADP | CC | ESDC |
|---|---|---|---|---|---|
| A | A | P | X |
Miscellaneous Management
| MOE (S_A) | SOS | AAC | QUP | UI | SLC | CIIC | RC | MCC | SVC |
|---|---|---|---|---|---|---|---|---|---|
| VA | I | 0 | VI | Q | U | V |
Management Control Army
| MATCAT 1 | MATCAT 2 | MATCAT 3 | MATCAT 4 5 | ARC |
|---|
Freight
| NMFC | NMFC SUB | UFC | HMC | LTL | LCL | WCC | TCC | SHC | ADC | ACC | ASH | NMF DESC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|